HIP1-ALK Fusion Variant in Non-Small-Cell Lung Cancer and Response to Crizotinib

被引：0

作者：

Wang, W. ^{[1
]}

Xu, C. ^{[2
]}

Zhang, Q. ^{[3
]}

Zhuang, W. ^{[4
]}

Zhu, Y. ^{[5
]}

Chen, Y. ^{[3
]}

Fang, M. ^{[1
]}

Chen, G. ^{[6
]}

机构：

[1] Zhejiang Canc Hosp, Hangzhou, Zhejiang, Peoples R China

[2] Fujian Canc Hosp, Fuzhou, Fujian, Peoples R China

[3] Fujian Canc Hosp, Pathol, Fuzhou, Fujian, Peoples R China

[4] Fujian Canc Hosp, Med Oncol, Fuzhou, Fujian, Peoples R China

[5] Zhejiang Rongjun Hosp, Jiaxing, Peoples R China

[6] Fujian Canc Hosp, Pathol, Fuzhou, Fujian, Peoples R China

来源：

关键词：

HIP1-ALK; NSCLC; crizotinib;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P3.CR-10

引用

页码：S1032 / S1032

页数：1